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Poster Session II S369greatly impacts their quality of life. Bedside nurses accompany these
patients and families on this journey and while educating and provid-
ing comfort along the way, these nurses advocate for assistance with
the larger multidisciplinary team to address the patient and family’s
concerns of comfort, quality of life, and possible outcomes.
The PBMTU Quality of Life Project (QoL) was created to em-
power the nurse to better identify, communicate, and assist the fam-
ily’s daily quality of life needs. The goal of the QoL Project is to
improve communication between patients, families, and the multi-
disciplinary medical care team, ensuring that conversations regard-
ing quality of life occur, are conveyed and understood by the entire
team, and a plan is developed which is tailored to that specific patient
and family’s desires. This ensures the path the patient follows is one
that has been fully understood and agreed upon by them and their
family, taking all factors into consideration. In turn, having the entire
medical team updated on the patient’s and families QoL choices
gives the nursing staff relief knowing that these issues have been ad-
dressed and the knowledge to continue caring for the patients effec-
tively and with regard to their specific desires.
TheQoL Project was submitted to the PBMTProgram’s Medical
Director in July 2009. After approval an assessment survey was com-
pleted with the nursing staff in August 2009. The results of the sur-
vey were presented to the entire PBMT Program which generated
many ideas and increased awareness for areas of improvements. After
six months of QoL interventions, in March 2010 the survey was re-
peated. A comparison of the two surveys, review of the interventions
and goals for the future were presented to the medical team in May
2010. The QoL Project was so successful that it has continued to
grow and is having a positive impact on the unit.
The oral presentation will begin with a slide show describing the
history, comparisons the two surveys, interventions, and suggestions
for the future, after which a discussion will take place.608
MANAGEMENT OF NAUSEA AND VOMITING IN THE PEDIATRIC BLOOD
AND MARROW TRANSPLANT SETTING – ARE WE COVERING ALL OF
OUR BASES? A NURSING PERSPECTIVE
Rowland, P. Children’s Healthcare System, Birmingham, AL
The challenge of managing nausea and vomiting (N/V) in the pe-
diatric blood and marrow transplant (BMT) setting is compounded
by multiday chemotherapy/radiation regimens and concomitant
treatments unique to the BMT process. Younger age has been iden-
tified as a particular risk for chemotherapy induced N/V thus in-
creasing the challenge further. An understanding of emetic
pathways affected by these treatments and medications recommen-
ded for each is essential to manage N/V effectively. Several organi-
zations have developed guidelines for antiemetic treatment. Many
recommendations are based on identification and blockage of emetic
pathways. While some organizations briefly address antiemetic rec-
ommendation for the pediatric population, none provide guidelines
for pediatric antiemetic recommendations in the BMT setting.
An evidence based practice group consisting of 13 pediatric BMT
nurses, one data manager, one supportive assistant and one pediatric
BMT nurse practitioner conducted a single institutional chart re-
view. Available medical charts of pediatric patients transplanted at
Alabama’s Childrens Healthcare System between Jan 2008 and April
2010 were reviewed to assess efficacy of N/V management. A com-
parison of treatments to present adult guidelines was completed.
Emetogenic potential for each preparative regimen was graded using
Hesketh’s algorithm for defining emetogenicity of combination reg-
imens. The Common Terminology Criteria for Adverse Events v3.0
(CTCAE) was utilized as a guideline to evaluate severity of daily
N/V.
Results of the chart review prompted a search of literature that
may provide information for treatment of N/V specific to the pedi-
atric population in the BMT setting. There were few articles ad-
dressing concerns of N/V in the pediatric population. It is the
recommendation of the EBP group that focus on research specific
to management of N/V in the pediatric BMT population become
a priority facilitating development of Antiemetic Guidelines specific
to the BMT pediatric population.609
THE POWER OF PROCESS IMPROVEMENT METHODOLOGY ON A HIGHLY
COMPLEX PEDIATRIC BONE MARROW TRANSPLANT UNIT’S CATHETER
ASSOCIATED BLOOD STREAM INFECTION RATES
Flesch, L.1, Demmel, K.M.1, Davies, S.M.1, Nagarajan, R.1,
Hawkins, D.1, Hutchinson, N.2, Bierman, L.1, Fellers, E.1, Hodapp, S.1,
O’Hara, E.1, Shelton, C.1, Curry, C.2, Giesken, R.2, Spear, S.3,
Wheeler, D.2, Giaccone, M.2 1Cincinnati Children’s Hospital Medical
Center, Cincinnati, OH; 2Cincinnati Children’s Hospital Medical Center,
Cincinnati, OH; 3Cincinnati Children’s Hospital Medical Center, Cincin-
nati, OH
Cincinnati Children’sHospitalMedical Center (CCHMC) has in-
stituted a major safety initiative to reduce central venous catheter
(CVC) blood stream infections (BSI). A multidisciplinary approach
utilizing quality improvement methodology was implemented ini-
tially in the PICU, leading to the development of a CVC mainte-
nance bundle.
With the bundle’s success, it was spread to CCHMC’s BMT pro-
gram that had the highest CVC BSI rates. The program, a highly
complex intensive care environment, completed 108 transplants in
2009 with approximately 70% unrelated, 10% matched sibling and
20% autologous. Until this point, line infections were viewed as a di-
rect treatment result leading to mucositis and increased vulnerability
to infection.
Initial support of this initiative was met with much resistance. On-
going communication regarding bundle progress and staff involve-
ment in the initiative through a unit based task force and
a national collaborative resulted in an augmented bundle. A signifi-
cant culture change with acceptance occurred as well. Staff has em-
braced responsibility for overall line infection rates and proactively
identifies infection prevention opportunities.
Ongoing tests of change created an enhanced bundle addressing
the unique challenges of a highly immune compromised population.
The bundle has evolved and includes line entry minimization, daily
line assessment, hand hygiene and site, line, and cap care practices.
The tests included evidence based product changes and review of
catheter and line practices. Specifically, weekly dressing changes,
the use of a biopatch, an occlusive transparent dressing, gloving
with all line care, a 30 second chlorhexidine scrub with every line en-
try, use of a positive pressure cap and masking of all parties during
sterile procedures were additional bundle elements.
CVC BSI rates have changed significantly. In 2006, the rate
reached 6.35 infections per 1000 catheter days. As of June 2010,
the rate was reduced to 1.68 infections per 1000 catheter days result-
ing in a 74% rate reduction.
Table 1. Cincinnati Children’s Hospital Medical Center Bone
Marrow Transplant Unit CVC BSI Rates
CVC BSI Per
FY (July-June) 1000 Line Days2005 5.45
2006 6.35
2007 4.83
2008 4.31
2009 1.98
2010 1.68610
INCREASED MOBILITY AND COMMITMENT TO EXERCISE DURING
HOSPITALIZATION HAS A POSITIVE EFFECT ON OUTCOMES FOR BONE
MARROW TRANSPLANT PATIENTS AT UNIVERSITY OF ALABAMA
HOSPITAL
Howard, R., McCay, W., Dockery, J., Madden, W. UAB, Birmingham,
AL
The Bone Marrow Transplant program staff at the University of
Alabama Hospital used a collaborative partnership approach with
their patients to increase and record physical activity in order to im-
prove clinical outcomes. Participants were encouraged to walk laps
around the unit and record their progress. Exercising in the hallways
